← Back to Screener
Milestone Scientific, Inc. Common Stock (MLSS)
Price$0.27
Favorite Metrics
Price vs S&P 500 (26W)-47.79%
Price vs S&P 500 (4W)-10.89%
Market Capitalization$21.40M
All Metrics
Book Value / Share (Quarterly)$0.04
P/TBV (Annual)7.85x
Revenue Growth (3Y)0.62%
Cash Flow / Share (Quarterly)$-0.04
Price vs S&P 500 (YTD)-5.28%
Gross Margin (TTM)71.40%
Net Profit Margin (TTM)-63.76%
EPS (TTM)$-0.07
10-Day Avg Trading Volume10.21M
EPS Excl Extra (TTM)$-0.07
Revenue Growth (5Y)10.53%
EPS (Annual)$-0.07
ROI (Annual)-156.03%
Gross Margin (Annual)71.40%
Net Profit Margin (5Y Avg)-70.79%
Cash / Share (Quarterly)$0.01
Revenue Growth QoQ (YoY)2.21%
ROA (Last FY)-73.30%
Revenue Growth TTM (YoY)3.99%
EBITD / Share (TTM)$-0.07
ROE (5Y Avg)-99.51%
Operating Margin (TTM)-63.48%
Cash Flow / Share (Annual)$-0.04
P/B Ratio7.61x
P/B Ratio (Quarterly)7.63x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.36x
Net Interest Coverage (TTM)-222.52x
ROA (TTM)-68.47%
EV / EBITDA (TTM)37.75x
EPS Incl Extra (Annual)$-0.07
Current Ratio (Annual)1.81x
Quick Ratio (Quarterly)0.44x
3-Month Avg Trading Volume1.39M
52-Week Price Return-70.92%
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$0.03
P/S Ratio (Annual)2.38x
Asset Turnover (Annual)1.15x
52-Week High$1.11
Operating Margin (5Y Avg)-72.05%
EPS Excl Extra (Annual)$-0.07
CapEx CAGR (5Y)-5.44%
Tangible BV CAGR (5Y)-29.66%
26-Week Price Return-43.81%
Quick Ratio (Annual)0.44x
13-Week Price Return-9.38%
Total Debt / Equity (Annual)0.30x
Current Ratio (Quarterly)1.81x
Enterprise Value$21.143
Revenue / Share Growth (5Y)4.86%
Asset Turnover (TTM)1.07x
Book Value / Share Growth (5Y)-32.65%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)0.50x
Pretax Margin (Annual)-63.76%
Cash / Share (Annual)$0.01
3-Month Return Std Dev78.91%
Gross Margin (5Y Avg)66.39%
Net Income / Employee (TTM)$-0
ROE (Last FY)-203.45%
Net Interest Coverage (Annual)-72.86x
EPS Basic Excl Extra (Annual)$-0.07
P/FCF (TTM)283.30x
Receivables Turnover (TTM)15.19x
Total Debt / Equity (Quarterly)0.30x
EPS Incl Extra (TTM)$-0.07
Receivables Turnover (Annual)15.19x
ROI (TTM)-144.83%
P/S Ratio (TTM)2.38x
Pretax Margin (5Y Avg)-71.62%
Revenue / Share (Annual)$0.11
Tangible BV / Share (Annual)$0.03
Price vs S&P 500 (52W)-100.75%
Year-to-Date Return-2.64%
5-Day Price Return-2.60%
EPS Normalized (Annual)$-0.07
ROA (5Y Avg)-56.07%
Net Profit Margin (Annual)-63.76%
Month-to-Date Return-7.71%
Cash Flow / Share (TTM)$-0.10
EBITD / Share (Annual)$-0.07
Operating Margin (Annual)-63.48%
LT Debt / Equity (Annual)0.28x
ROI (5Y Avg)-89.77%
LT Debt / Equity (Quarterly)0.28x
EPS Basic Excl Extra (TTM)$-0.07
P/TBV (Quarterly)7.85x
P/B Ratio (Annual)7.63x
Inventory Turnover (TTM)0.50x
Pretax Margin (TTM)-63.76%
Book Value / Share (Annual)$0.04
Price vs S&P 500 (13W)-10.06%
Beta0.93x
P/FCF (Annual)76.43x
Revenue / Share (TTM)$0.11
ROE (TTM)-173.87%
52-Week Low$0.22
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
MLSSMilestone Scientific, Inc. Common Stock | 2.38x | 10.53% | 71.40% | -63.48% | $0.27 |
ISRGIntuitive Surgical Inc. | 16.35x | 18.22% | 66.00% | 29.27% | $458.08 |
EWEdwards Lifesciences Corp | 7.42x | 6.70% | 78.01% | 18.41% | $79.05 |
STESTERIS plc | 3.70x | 12.49% | 44.11% | 17.03% | $219.97 |
ZBHZimmer Biomet Holdings, Inc. | 2.28x | 3.22% | 69.71% | 13.34% | $94.78 |
ALGNAlign Technology Inc | 3.29x | 10.30% | 68.27% | 13.53% | $185.02 |
SNNSmith & Nephew plc | 2.36x | 6.21% | 68.01% | 12.88% | $33.83 |
MSAMine Safety Incorporated | 3.40x | 6.82% | 46.46% | 19.83% | $165.17 |
ESTAEstablishment Labs Holdings Inc. | 8.96x | 20.04% | 69.32% | -18.48% | $64.51 |
ENOVEnovis Corporation | 0.65x | -6.05% | 58.16% | -50.09% | $25.20 |
CDRECadre Holdings, Inc. | 2.32x | 8.57% | 42.54% | 11.04% | $30.43 |
About
Milestone Scientific Inc. manufactures proprietary, computer-controlled systems for delivering local anesthetics with improved comfort and reduced pain. The company serves the dental market through its CompuDent system and the medical market through its CompuMed system.